Trial Profile
A retrospective, multi-centre trial to evaluate the efficacy and safety of abacavir/lamivudine (Kivexa) plus rilpivirine in treatment naive HIV infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Lamivudine/abacavir (Primary) ; Rilpivirine (Primary) ; Emtricitabine/rilpivirine/tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2016 New trial record